Crossmark

Design of experiment avenue for development and validation of RP-HPLC-PDA method for determination of apremilast in bulk and in in-house tablet formulation

Crossref DOI link: https://doi.org/10.1186/s40543-019-0170-8

Published Online: 2019-02-27

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chaudhari, Suraj R. https://orcid.org/0000-0002-9778-5478
Shirkhedkar, Atul A.
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 20 November 2018

Accepted: 11 February 2019

First Online: 27 February 2019

Competing interests

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below